A national project will evaluate a new PCR test to improve early diagnosis of severe fungal infections in high‑risk patients
15/05/2026
Immunocompromised individuals are people whose immune system is impaired and therefore have a reduced ability to defend themselves against infections. This condition may result from an underlying disease, immunosuppressive treatment, cancer, organ transplantation, or, more rarely, a genetic disorder. Infections remain one of the leading causes of complications and mortality in these patients. For this reason, it is essential to develop new prevention, diagnostic, and treatment strategies to improve their prognosis and quality of life.
Advances in medicine have made it possible for an increasing number of people to survive complex oncological, hematological, and chronic diseases. As a result, the population of immunocompromised patients continues to grow steadily.
Many of the infections affecting these patients are caused by opportunistic microorganisms that do not usually cause disease in individuals with a healthy immune system. Detecting and treating these infections appropriately remains a major clinical challenge.
In this context, our research focuses on four main objectives:
- Developing effective strategies to prevent infections.
- Improving early diagnosis through novel microbiological and immunological tools.
- Adapting infection management to new treatments and emerging patient profiles.
- Developing innovative therapies that help reduce mortality and associated complications.
15/05/2026
05/05/2026
13/04/2026
Co-Head of Section for Immunosuppressed Patients – Doctor and Researcher
Co-Head of Section for Immunosuppressed Patients – Doctor and Researcher
Specialist in Internal Medicine, trained at Bellvitge University Hospital. He obtained his PhD from the University of Barcelona in 2020. He worked as an Infectious Diseases specialist at Hospital Clínic de Barcelona from 2017 to 2024. He is currently Co-Head of the Immunocompromised Patients Section at the Fundació Lluita contra les Infeccions and Germans Trias i Pujol Hospital in Badalona. He is a member of the Executive Board of the Spanish Medical Mycology Group (SEIMC). His areas of expertise include fungal infections and multidrug-resistant microorganisms.
Co-Head of Section for Immunosuppressed Patients and Head of Severe Bacterial Infections – Doctor and Researcher
Co-Head of Section for Immunosuppressed Patients and Head of Severe Bacterial Infections – Doctor and Researcher
Medical specialist. PhD in Medicine. Co-Head of the Immunocompromised Patients and Severe Bacterial Infections Section at the Fundació Lluita contra les Infeccions and Germans Trias i Pujol University Hospital. She has played an active role in designing outpatient care pathways and hospital-at-home programmes for patients receiving antibiotic treatment. She also provides inpatient clinical care. She supervises Internal Medicine residents and is actively involved in the research lines of the Internal Medicine Unit (IMU). She is a Full Professor of Medicine at the Universitat Autònoma de Barcelona (UAB) and is responsible for the Clinical Practice course within the UAB Medical Degree programme at the Can Ruti Campus.
Doctor and Researcher
Doctor and Researcher
Doctor and Researcher
Doctor and Researcher
We need your support to continue conducting independent clinical research with the aim of treating and curing people with an infectious disease.